Galen Specialty Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GALEN SPECIALTY
GALEN SPECIALTY has one approved drug.
Drugs and US Patents for Galen Specialty
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Galen Specialty
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | 6,546,281 | ⤷ Start Trial |
| Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | 5,658,583 | ⤷ Start Trial |
| Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | 6,780,426 | ⤷ Start Trial |
| Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | 6,306,431 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

